Cases of respiratory syncytial virus are increasing, but vaccines and antibody shots can keep young children out of the ...
“Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma,” CURE; ...
Michael Wang, MD, highlights standout translational studies from ASH 2025 that advance understanding of prognosis and drug ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
The educational campaign will focus on teaching the American public about antibodies and preventing infectious diseaseThe collaboration will ...
After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who ...
More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal ...
The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...
Welcome, everyone, to the JPMorgan Healthcare Conference. We are pleased to have with us the Almirall management team here with us today, Carlos Gallardo, Chairman and CEO; Karl Ziegelbauer, CFO; Jon ...
By CH Unnikrsihnan Drug maker and researcher Glenmark Pharmaceuticals Ltd's new biological drug candidate Bi-Specific ...
A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for ...
More than 140 U.S. medical organizations are advocating for the passage of a bill that would increase NIH funding for fiscal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results